ACE2 and COVID-19: Understanding these changes at the molecular level, combined with the genotype and epidemiological data will allow the elucidation of population risk profiles and also help advance therapeutics such as a rationally designed soluble ACE2 decoy-receptor for treatment of COVID-19.